Abstract:The genetic make-up of an individual contributes to the susceptibility and response to viral infection. Although environmental, clinical and social factors have a role in the chance of exposure to SARS-CoV-2 and the severity of COVID-191,2, host genetics may also be important. Identifying host-specific genetic factors may reveal biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We formed a global network of researchers to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity. Here we describe the results of three genome-wide association meta-analyses that consist of up to 49,562 patients with COVID-19 from 46 studies across 19 countries. We report 13 genome-wide significant loci that are associated with SARS-CoV-2 infection or severe manifestations of COVID-19. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases3-7. They also represent potentially actionable mechanisms in response to infection. Mendelian randomization analyses support a causal role for smoking and body-mass index for severe COVID-19 although not for type II diabetes. The identification of novel host genetic factors associated with COVID-19 was made possible by the community of human genetics researchers coming together to prioritize the sharing of data, results, resources and analytical frameworks. This working model of international collaboration underscores what is possible for future genetic discoveries in emerging pandemics, or indeed for any complex human disease.

The Covid-19 Pandemic From A Human Genetic Perspective

Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.

Profiling COVID-19 Genetic Research: A Data-Driven Study Utilizing Intelligent Bibliometrics.

A Genomic Perspective on the Origin and Emergence of SARS-CoV-2

The human genetic epidemiology of COVID-19

Human genetic basis of severe or critical illness in COVID-19

The emergence, genomic diversity and global spread of SARS-CoV-2

Genomic epidemiology reveals early transmission of SARS-CoV-2 and mutational dynamics in Nanning, China

An overview of human proteins and genes involved in SARS-CoV-2 infection

Genotyping coronavirus SARS-CoV-2: methods and implications

COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses

Semantic and Population Analysis of the Genetic Targets Related to COVID-19 and Its Association with Genes and Diseases

Mapping the human genetic architecture of COVID-19

Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences

Towards precision medicine: Omics approach for COVID-19

Similarities and Evolutionary Relationships of COVID-19 and Related Viruses

A Crowned Killer’s Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2

Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review

COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2

Epidemiological and Genomic Analysis of SARS-CoV-2 in 10 Patients From a Mid-Sized City Outside of Hubei, China in the Early Phase of the COVID-19 Outbreak

Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses